149 related articles for article (PubMed ID: 22631037)
1. Hypercoagulability in non-transfusion-dependent thalassemia.
Cappellini MD; Musallam KM; Poggiali E; Taher AT
Blood Rev; 2012 Apr; 26 Suppl 1():S20-3. PubMed ID: 22631037
[TBL] [Abstract][Full Text] [Related]
2. [Advances in pathogenesis and correlated clinical research of hypercoagulability in β thalassemia].
Lv RY; Wen FQ; Yu J
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):774-8. PubMed ID: 25008893
[TBL] [Abstract][Full Text] [Related]
3. The hypercoagulable state in thalassemia intermedia.
Taher AT; Musallam KM; Inati A
Hemoglobin; 2009; 33 Suppl 1():S160-9. PubMed ID: 20001621
[TBL] [Abstract][Full Text] [Related]
4. Coagulation and splenectomy: an overview.
Cappellini MD; Grespi E; Cassinerio E; Bignamini D; Fiorelli G
Ann N Y Acad Sci; 2005; 1054():317-24. PubMed ID: 16339680
[TBL] [Abstract][Full Text] [Related]
5. Intravascular hemolysis, vascular endothelial cell activation and thrombophilia in splenectomized patients with hemoglobin E/β-thalassemia disease.
Atichartakarn V; Chuncharunee S; Archararit N; Udomsubpayakul U; Aryurachai K
Acta Haematol; 2014; 132(1):100-7. PubMed ID: 24525823
[TBL] [Abstract][Full Text] [Related]
6. Hemostatic alterations in splenectomized and non-splenectomized patients with beta-thalassemia/hemoglobin E disease.
Tripatara A; Jetsrisuparb A; Teeratakulpisarn J; Kuaha K
Thromb Res; 2007; 120(6):805-10. PubMed ID: 17382994
[TBL] [Abstract][Full Text] [Related]
7. Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability.
Ataga KI; Cappellini MD; Rachmilewitz EA
Br J Haematol; 2007 Oct; 139(1):3-13. PubMed ID: 17854302
[TBL] [Abstract][Full Text] [Related]
8. Erythrocytic phosphatidylserine exposure and hemostatic alterations in β-thalassemia intermediate patients.
Zahedpanah M; Azarkeivan A; Aghaieepour M; Nikogoftar M; Ahmadinegad M; Hajibeigi B; Tabatabaiee MR; Maghsudlu M
Hematology; 2014 Dec; 19(8):472-6. PubMed ID: 24620948
[TBL] [Abstract][Full Text] [Related]
9. Platelet and not erythrocyte microparticles are procoagulant in transfused thalassaemia major patients.
Agouti I; Cointe S; Robert S; Judicone C; Loundou A; Driss F; Brisson A; Steschenko D; Rose C; Pondarré C; Bernit E; Badens C; Dignat-George F; Lacroix R; Thuret I
Br J Haematol; 2015 Nov; 171(4):615-24. PubMed ID: 26205481
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state.
Singer ST; Kuypers FA; Styles L; Vichinsky EP; Foote D; Rosenfeld H
Am J Hematol; 2006 Sep; 81(9):670-5. PubMed ID: 16795058
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of platelet- and red cell-derived extracellular vesicles in transfusion-dependent β-thalassemia/HbE patients with pulmonary arterial hypertension.
Manakeng K; Prasertphol P; Phongpao K; Chuncharunee S; Tanyong D; Worawichawong S; Svasti S; Chaichompoo P
Ann Hematol; 2019 Feb; 98(2):281-288. PubMed ID: 30334069
[TBL] [Abstract][Full Text] [Related]
12. Soluble endothelial adhesion molecules and inflammation markers in patients with beta-thalassemia intermedia.
Kanavaki I; Makrythanasis P; Lazaropoulou C; Tsironi M; Kattamis A; Rombos I; Papassotiriou I
Blood Cells Mol Dis; 2009; 43(3):230-4. PubMed ID: 19654073
[TBL] [Abstract][Full Text] [Related]
13. Thalassemia and the hypercoagulable state.
Sirachainan N
Thromb Res; 2013; 132(6):637-41. PubMed ID: 24125597
[TBL] [Abstract][Full Text] [Related]
14. Cerebral infarction in β-thalassemia intermedia: breaking the silence.
Musallam KM; Taher AT; Karimi M; Rachmilewitz EA
Thromb Res; 2012 Nov; 130(5):695-702. PubMed ID: 22857801
[TBL] [Abstract][Full Text] [Related]
15. Platelet aggregation and activation in thalassemia major patients in Indonesia.
Setiabudy R; Wahidiyat PA; Setiawan L
Clin Appl Thromb Hemost; 2008 Jul; 14(3):346-51. PubMed ID: 18160592
[TBL] [Abstract][Full Text] [Related]
16. Hypercoagulability in β-thalassemia: a status quo.
Cappellini MD; Poggiali E; Taher AT; Musallam KM
Expert Rev Hematol; 2012 Oct; 5(5):505-11; quiz 512. PubMed ID: 23146054
[TBL] [Abstract][Full Text] [Related]
17. Study of platelet activation, hypercoagulable state, and the association with pulmonary hypertension in children with β-thalassemia.
Fayed MA; Abdel-Hady HE; Hafez MM; Salama OS; Al-Tonbary YA
Hematol Oncol Stem Cell Ther; 2018 Jun; 11(2):65-74. PubMed ID: 28633041
[TBL] [Abstract][Full Text] [Related]
18. Hemostatic and thrombotic markers in patients with hemoglobin E/beta-thalassemia disease.
Angchaisuksiri P; Atichartakarn V; Aryurachai K; Archararit N; Chuncharunee S; Tiraganjana A; Rattanasiri S
Am J Hematol; 2007 Nov; 82(11):1001-4. PubMed ID: 17654509
[TBL] [Abstract][Full Text] [Related]
19. Microparticles from splenectomized β-thalassemia/HbE patients play roles on procoagulant activities with thrombotic potential.
Klaihmon P; Phongpao K; Kheansaard W; Noulsri E; Khuhapinant A; Fucharoen S; Morales NP; Svasti S; Pattanapanyasat K; Chaichompoo P
Ann Hematol; 2017 Feb; 96(2):189-198. PubMed ID: 27900452
[TBL] [Abstract][Full Text] [Related]
20. Increased platelet adhesion under flow conditions is induced by both thalassemic platelets and red blood cells.
Goldschmidt N; Spectre G; Brill A; Zelig O; Goldfarb A; Rachmilewitz E; Varon D
Thromb Haemost; 2008 Nov; 100(5):864-70. PubMed ID: 18989531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
